Search/
Company exports
CSV downloadsPro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
Semicap·ASML.AS
ASML Holding N.V.
AMS · NL
Lithography platform supplier for leading-edge logic, memory, and advanced packaging flows.
AI relevance
Critical EUV and DUV lithography choke point for AI accelerator and HBM capacity.
Price
$1657.80
Change
-18.20 (-1.09%)
Market cap
$638.9B
52w range
$588–$1691
Exchange
AMS
Country
NL
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Price chart
ASML.AS market performance
Daily close for ASML Holding N.V.
- Latest close
- $1,658
- Range move
- +$1,005 (+153.8%)
- Range high
- $1,676
- Range low
- $592.9
- Latest volume
- 2.6M
- Source
- FMP EOD
Downloads
CSVExports
Download statements, ratios, chart data, and transcript indexes.
Income statement
12 annual rowsRevenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Balance sheet
12 annual rowsCash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Cash flow
12 annual rowsOperating cash flow, capital expenditures, and free cash flow.
Key metrics
12 annual rowsEnterprise value, valuation multiples, returns, yields, and cash conversion.
Ratios
12 annual rowsMargins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Chart data
1281 rowsFive years of daily close and volume data powering the company chart.
Transcript list
72 rowsAvailable earnings-call transcript dates by fiscal year and quarter.
StreetBuy
Analyst expectations
Rating consensus39 ratings
Strong buy
0
Buy
21
Hold
15
Sell
3
Strong sell
0
Annual estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $39.26B | $36.69B - $41.43B | $31.89 | $28.96 - $35.27 | $15.08B | $13.20B | $12.11B | $1.54B | 37 rev / 32 EPS |
| 2027-12-31 | $48.14B | $41.71B - $55.70B | $42.76 | $35.12 - $55.59 | $18.48B | $16.18B | $16.01B | $1.89B | 37 rev / 31 EPS |
| 2028-12-31 | $53.43B | $53.32B - $53.55B | $50.56 | $41.29 - $64.56 | $20.52B | $17.96B | $18.38B | $2.10B | 27 rev / 19 EPS |
| 2029-12-31 | $60.70B | $54.46B - $67.46B | $60.12 | $52.08 - $68.81 | $23.31B | $20.40B | $23.38B | $2.38B | 13 rev / 9 EPS |
| 2030-12-31 | $64.20B | $57.60B - $71.35B | $65.95 | $57.13 - $75.49 | $24.65B | $21.58B | $25.65B | $2.52B | 13 rev / 15 EPS |
Quarterly estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.92B | $8.72B - $9.49B | $6.87 | $6.62 - $7.42 | $3.42B | $3.00B | $2.65B | $349.6M | 18 rev / 14 EPS |
| 2026-09-30 | $10.19B | $9.56B - $11.58B | $8.27 | $7.35 - $9.89 | $3.91B | $3.42B | $3.19B | $399.5M | 16 rev / 12 EPS |
| 2026-12-31 | $11.47B | $10.98B - $12.66B | $9.61 | $9.07 - $10.90 | $4.41B | $3.86B | $3.71B | $449.9M | 15 rev / 10 EPS |
| 2027-03-31 | $10.96B | $10.48B - $12.09B | $9.34 | $8.82 - $10.60 | $4.21B | $3.68B | $3.60B | $429.6M | 11 rev / 5 EPS |
| 2027-06-30 | $11.20B | $10.72B - $12.36B | $9.56 | $9.02 - $10.84 | $4.30B | $3.77B | $3.69B | $439.4M | 8 rev / 5 EPS |
| 2027-09-30 | $12.13B | $11.61B - $13.38B | $10.60 | $10.01 - $12.02 | $4.66B | $4.08B | $4.09B | $475.7M | 8 rev / 5 EPS |
| 2027-12-31 | $13.25B | $12.68B - $14.62B | $11.83 | $11.17 - $13.42 | $5.09B | $4.45B | $4.56B | $519.5M | 15 rev / 5 EPS |
| 2028-03-31 | $11.68B | $11.17B - $12.88B | $10.35 | $9.77 - $11.74 | $4.48B | $3.92B | $3.99B | $457.9M | 10 rev / 7 EPS |
Price target history
No price target summary on file.
Latest grade actions
| Date | Firm | Action | Previous | New |
|---|---|---|---|---|
| 2023-10-18 | JP Morgan | Maintain | Overweight | Overweight |
| 2023-10-11 | Susquehanna | Maintain | Positive | Positive |
| 2023-10-10 | JP Morgan | Maintain | Overweight | Overweight |
| 2023-07-27 | Bernstein | Downgrade | Outperform | Market Perform |
| 2023-07-19 | Wells Fargo | Maintain | Overweight | Overweight |
| 2023-06-15 | New Street Research | Downgrade | Buy | Neutral |
| 2023-01-25 | Argus Research | Maintain | Buy | Buy |
| 2023-01-25 | JP Morgan | Maintain | Overweight | Overweight |
Historical rating snapshots
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-06-01 | 6 | 32 | 5 | 1 | 1 |
| 2026-05-01 | 6 | 32 | 5 | 1 | 0 |
| 2026-04-01 | 6 | 32 | 6 | 1 | 0 |
| 2026-03-01 | 6 | 31 | 6 | 1 | 1 |
| 2026-02-01 | 6 | 31 | 6 | 1 | 1 |
| 2026-01-01 | 6 | 29 | 9 | 1 | 1 |
| 2025-12-01 | 4 | 23 | 10 | 1 | 0 |
| 2025-11-01 | 4 | 23 | 11 | 1 | 0 |
FinancialsFY 2025
Financials
Income statement annual
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $32.67B | $17.26B | 52.8% | $4.70B | $11.30B | $12.43B | $9.61B | $24.73 |
| FY 2024 | $28.26B | $14.08B | 49.8% | $3.94B | $9.02B | $10.18B | $7.57B | $19.25 |
| FY 2023 | $27.56B | $13.84B | 50.2% | $3.72B | $9.04B | $10.02B | $7.84B | $19.91 |
| FY 2022 | $21.17B | $10.47B | 49.5% | $3.07B | $6.50B | $7.16B | $5.62B | $14.14 |
| FY 2021 | $18.61B | $9.65B | 51.9% | $2.43B | $6.54B | $7.21B | $5.88B | $14.36 |
| FY 2020 | $13.98B | $6.63B | 47.4% | $2.07B | $4.05B | $4.54B | $3.55B | $8.49 |
| FY 2019 | $11.82B | $5.13B | 43.4% | $1.84B | $2.79B | $3.24B | $2.59B | $6.13 |
| FY 2018 | $10.94B | $4.90B | 44.8% | $1.47B | $2.97B | $3.40B | $2.59B | $5.94 |
| FY 2017 | $8.96B | $3.90B | 43.5% | $1.15B | $2.34B | $2.86B | $2.07B | $4.93 |
| FY 2016 | $6.88B | $2.94B | 42.7% | $1.03B | $1.56B | $2.08B | $1.47B | $3.46 |
| FY 2015 | $6.29B | $2.84B | 45.2% | $1.05B | $1.48B | $1.87B | $1.39B | $3.22 |
| FY 2014 | $5.86B | $2.54B | 43.4% | $1.05B | $1.20B | $1.55B | $1.20B | $2.74 |
Cash flow annual
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $12.66B | $1.63B | $11.08B |
| FY 2024 | $11.17B | $2.07B | $9.08B |
| FY 2023 | $5.44B | $2.20B | $3.25B |
| FY 2022 | $8.49B | $2.21B | $7.22B |
| FY 2021 | $10.85B | $940.3M | $9.91B |
| FY 2020 | $4.63B | $1.00B | $3.63B |
| FY 2019 | $3.28B | $1.19B | $2.46B |
| FY 2018 | $3.30B | $838.3M | $2.46B |
| FY 2017 | $1.80B | $358.0M | $1.44B |
| FY 2016 | $1.67B | $324.7M | $1.34B |
| FY 2015 | $2.03B | $372.9M | $1.65B |
| FY 2014 | $1.37B | $706.4M | $667.9M |
Balance sheet annual
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $13.32B | $4.17B | $11.43B | $8.23B | $50.57B | $2.71B | -$10.21B | $30.95B | $19.61B |
| FY 2024 | $12.74B | $5.44B | $11.71B | $7.23B | $48.59B | $4.69B | -$8.05B | $30.11B | $18.48B |
| FY 2023 | $7.01B | $7.26B | $9.54B | $5.80B | $39.96B | $4.63B | -$2.37B | $26.51B | $13.45B |
| FY 2022 | $7.38B | $7.05B | $7.68B | $4.14B | $36.30B | $4.26B | -$3.01B | $27.49B | $8.81B |
| FY 2021 | $7.59B | $4.56B | $5.47B | $3.15B | $30.23B | $4.58B | -$2.37B | $20.09B | $10.14B |
| FY 2020 | $7.35B | $3.33B | $4.84B | $2.82B | $27.27B | $4.68B | -$1.37B | $13.40B | $13.87B |
| FY 2019 | $4.72B | $2.85B | $4.02B | $2.32B | $22.63B | $3.11B | -$424.0M | $10.04B | $12.59B |
| FY 2018 | $4.03B | $2.40B | $3.67B | $1.73B | $20.14B | $3.03B | -$94.6M | $8.50B | $11.64B |
| FY 2017 | $3.29B | $2.20B | $3.07B | $1.71B | $18.19B | $3.03B | $766.3M | $7.41B | $10.78B |
| FY 2016 | $4.06B | $1.22B | $2.85B | $1.69B | $17.21B | $3.32B | $412.6M | $7.39B | $9.82B |
| FY 2015 | $3.41B | $1.16B | $2.65B | $1.62B | $13.30B | $1.13B | -$1.33B | $4.91B | $8.39B |
| FY 2014 | $2.75B | $1.49B | $2.62B | $1.45B | $12.20B | $1.15B | -$1.27B | $4.69B | $7.51B |
Annual ratios and key metrics
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 52.8% | 34.6% | 29.4% | 1.3x | 0.8x | 49.0% | 35.5% | 10.6x | 28.0x | 3.1% | 14.4% | 317d |
| FY 2024 | 49.8% | 31.9% | 26.8% | 1.5x | 0.9x | 41.0% | 25.0% | 9.2x | 25.4x | 3.4% | 13.9% | 282d |
| FY 2023 | 50.2% | 32.8% | 28.4% | 1.5x | 0.9x | 58.3% | 32.3% | 9.4x | 25.9x | 1.2% | 13.5% | 287d |
| FY 2022 | 49.5% | 30.7% | 26.6% | 1.3x | 0.9x | 63.8% | 29.1% | 9.3x | 27.6x | 3.6% | 14.5% | 296d |
| FY 2021 | 51.9% | 35.1% | 31.6% | 1.5x | 1.0x | 58.0% | 30.2% | 15.4x | 39.8x | 3.4% | 13.1% | 226d |
| FY 2020 | 47.4% | 29.0% | 25.4% | 2.4x | 1.7x | 25.6% | 17.0% | 11.8x | 36.4x | 2.2% | 14.8% | 259d |
| FY 2019 | 43.4% | 23.6% | 21.9% | 2.6x | 1.7x | 20.6% | 14.5% | 9.4x | 34.1x | 2.2% | 15.6% | 250d |
| FY 2018 | 44.8% | 27.1% | 23.7% | 2.8x | 1.8x | 22.3% | 16.0% | 5.5x | 17.8x | 4.2% | 13.4% | 243d |
| FY 2017 | 43.5% | 26.2% | 23.1% | 2.8x | 1.8x | 19.2% | 13.6% | 7.2x | 22.5x | 2.3% | 12.9% | 251d |
| FY 2016 | 42.7% | 22.7% | 21.4% | 2.6x | 1.7x | 15.0% | 9.6% | 6.7x | 22.0x | 3.0% | 14.9% | 279d |
| FY 2015 | 45.2% | 23.6% | 22.1% | 2.5x | 1.6x | 16.5% | 13.0% | 5.4x | 18.3x | 4.6% | 16.6% | 292d |
| FY 2014 | 43.4% | 20.5% | 20.4% | 2.5x | 1.6x | 15.9% | 12.1% | 6.5x | 24.4x | 1.7% | 18.0% | 327d |
Annual growth
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | +15.6% | +22.6% | +19.2% | +25.3% | +26.9% | +28.5% | +22.0% | +24.5% | +4.6% | -2.4% | +4.1% | -42.2% |
| FY 2024 | +2.6% | +1.8% | +5.8% | -0.2% | -3.4% | -3.3% | +179.7% | +5.1% | +81.8% | +22.7% | +21.6% | +1.2% |
| FY 2023 | +30.2% | +32.1% | +21.3% | +39.1% | +39.4% | +40.8% | -55.0% | -71.3% | -5.0% | +24.3% | +10.1% | +8.7% |
| FY 2022 | +13.8% | +8.5% | +26.3% | -0.5% | -4.4% | -1.5% | -27.1% | -36.3% | -2.8% | +40.5% | +20.1% | -7.1% |
| FY 2021 | +33.1% | +45.6% | +17.5% | +61.3% | +65.6% | +69.1% | +173.1% | +6.0% | +3.2% | +13.1% | +10.9% | -2.0% |
| FY 2020 | +18.3% | +29.2% | +12.2% | +45.2% | +37.1% | +38.5% | +47.2% | +16.0% | +55.8% | +20.1% | +20.5% | +50.5% |
| FY 2019 | +8.0% | +4.8% | +25.5% | -5.9% | +0.0% | +3.2% | +0.0% | -42.1% | +16.9% | +9.6% | +12.4% | +2.7% |
| FY 2018 | +22.1% | +25.6% | +27.2% | +26.5% | +25.4% | +20.5% | +71.0% | -134.2% | +22.7% | +19.7% | +10.7% | +0.0% |
| FY 2017 | +30.4% | +32.8% | +12.5% | +49.9% | +40.4% | +42.6% | +7.4% | -10.3% | -18.9% | +7.5% | +5.7% | -8.9% |
| FY 2016 | +9.3% | +3.4% | -1.9% | +5.5% | +6.1% | +7.4% | -18.8% | +12.9% | +19.0% | +7.7% | +29.4% | +193.8% |
| FY 2015 | +7.4% | +12.0% | -0.8% | +23.4% | +15.9% | +17.6% | +147.4% | +47.2% | +23.8% | +1.1% | +8.9% | -2.1% |
| FY 2014 | +11.6% | +19.5% | +22.1% | +22.1% | +17.8% | +15.8% | -20.7% | -31.2% | -8.5% | +5.1% | +6.0% | +7.4% |
Segments
Revenue Mix
Revenue segmentation data unavailable.
Transcripts72 on file
Transcripts
Events
Events
Next earnings
2026-07-15EPS est $6.87